Equasens SA (EQSE)

Currency in EUR
39.55
-0.95(-2.35%)
Closed·
Earnings results expected in 4 days
EQSE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.5540.60
52 wk Range
33.7053.70
Key Statistics
Prev. Close
40.5
Open
40.5
Day's Range
39.55-40.6
52 wk Range
33.7-53.7
Volume
9.01K
Average Volume (3m)
11.2K
1-Year Change
12.0332%
Book Value / Share
15.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EQSE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
53.14
Upside
+34.36%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 23 consecutive years

Equasens SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.

Employees
1400
Market
France

Compare EQSE to Peers and Sector

Metrics to compare
EQSE
Peers
Sector
Relationship
P/E Ratio
16.8x14.7x−0.5x
PEG Ratio
−1.210.230.00
Price/Book
2.6x1.5x2.6x
Price / LTM Sales
2.7x1.9x3.2x
Upside (Analyst Target)
32.7%16.6%47.4%
Fair Value Upside
Unlock8.4%7.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 53.14
(+34.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.40%
Dividend Yield
3.05%
Industry Median 2.37%
Annualised payout
1.25
Paid annually
5-Years Growth
+6.79%
Growth Streak

Earnings

Latest Release
30/03/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

8.35
ALKAL
+38.70%
0.3785
ALSEN
-1.30%
359.00
IDLA
+0.56%
64.40
VCTP
+2.55%

FAQ

What Is the Equasens (Paris: EQSE) Share Price Today?

The Equasens stock price today is 39.55 EUR.

What Stock Exchange Does Equasens (EQSE) Trade On?

Equasens is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Equasens?

The stock symbol (also called a 'ticker') for Equasens is "EQSE."

Does Equasens Pay Dividends? What’s The Current EQSE Dividend Yield?

Yes, EQSE Pays Dividends to its Shareholders. The current Equasens dividend yield is 3.09%.

What Is the Current Equasens Market Capitalisation?

As of today, Equasens (Paris: EQSE) market cap is 594.48M EUR.

What Is Equasens's (EQSE) Earnings Per Share (TTM)?

The Equasens EPS is currently 2.40 (Trailing Twelve Months).

When Is the Next Equasens Earnings Date?

Equasens's next earnings report will be released on 29/04/2026.

Is EQSE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Equasens moving averages and other technical indicators, the daily buy/sell signal for EQSE stock is Neutral.

How Many Times Has Equasens Stock Split?

Equasens has split 1 times. (See the EQSE stock split history page for full effective split date and price information.)

How Many Employees Does Equasens Have?

Equasens has 1400 employees, based on their latest Companies House report.

What is the current trading status of Equasens (Paris: EQSE)?

As of 25/04/2026, Equasens (EQSE) is trading at a share price of 39.55 EUR, with a previous close of 40.50 EUR. The stock has fluctuated within a day range of 39.55 EUR to 40.60 EUR, while its 52-week range spans from 33.70 EUR to 53.70 EUR.

What Is Equasens (EQSE) Price Target According to Analysts?

The average 12-month price target for Equasens is 53.14 EUR, with a high estimate of 63.7 EUR and a low estimate of 42 EUR. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.36% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.